4//SEC Filing
Falcon Fund 2 Holding Company, L.P. 4
Accession 0000950170-23-073331
CIK 0001376339other
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 4:47 PM ET
Size
7.8 KB
Accession
0000950170-23-073331
Insider Transaction Report
Form 4
Falcon Fund 2 Holding Company, L.P.
10% Owner
Transactions
- Conversion
Series B Preferred Stock, par value $0.001 per share
2023-12-22−90,000→ 0 totalExercise: $3.85→ Common Stock (28,195,249 underlying) - Conversion
Common Stock, par value $0.001 per share
2023-12-22+28,195,249→ 28,195,249 total
Footnotes (1)
- [F1]On December 22, 2023, all 90,000 shares of Series B Preferred Stock, par value $0.001 per share, with a liquidation preference of $1,000.00 per share ("Series B Preferred Stock"), of MiMedx Group, Inc. (the "Issuer") held by Falcon Fund 2 Holding Company, L.P. (the "Reporting Person"), which were previously acquired by the Reporting Person on June 30, 2020, mandatorily converted into an aggregate 28,195,249 shares of common stock, par value $0.001 per share ("Common Stock"), of the Issuer, in accordance with the terms of the Series B Preferred Stock, which amount is inclusive of 4,818,626 shares of Common Stock issuable to the Reporting Person as a dividend.
Documents
Issuer
MIMEDX GROUP, INC.
CIK 0001376339
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001817718
Filing Metadata
- Form type
- 4
- Filed
- Dec 26, 7:00 PM ET
- Accepted
- Dec 27, 4:47 PM ET
- Size
- 7.8 KB